AMA submission to the Therapeutic Goods Administration – proposed amendments to the Poisons Standard – March 2020 proposals
In this submission, the AMA opposes reliance on pharmacy uploads to the patient’s My Health Record to support down-scheduling medicines that without the My Health Record would otherwise be considered unsafe to supply over the counter. The AMA opposes the down-scheduling of ondansetron, adapalene, and nicotine. The AMA supports the proposals to increase access to ranitidine, fexofenadine, flurbiprofen, rizatriptan, and melatonin. The AMA supports the changes to pentobarbital and selective serotonin reuptake inhibitors (SSRIs).